Evidence map›Paper›PMID 23804093›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice.

Snehajyoti Chatterjee, Pushpak Mizar, Raphaelle Cassel, Romain Neidl, B Ruthrotha Selvi, Dalvoy Vasudevarao Mohankrishna, Bhusainahalli M Vedamurthy, Anne Schneider, Olivier Bousiges, Chantal Mathis and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 164 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Eosinophils in Rheumatoid Arthritis: A Multifaceted Role in the Pathogenesis of the Disease.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Molecular and functional characterization of an evolutionarily conserved CREB-binding protein in the Lymnaea CNS.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Snehajyoti ChatterjeeTranscription and Disease Laboratory, Molecular Biology and Genetics Unit, and Chemistry and Physics of Materials Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bangalore 560064, India.
Pushpak Mizar
Raphaelle Cassel
Romain Neidl
B Ruthrotha Selvi
Dalvoy Vasudevarao Mohankrishna
Bhusainahalli M Vedamurthy
Anne Schneider
Olivier Bousiges
Chantal Mathis
Jean-Christophe Cassel
Muthusamy Eswaramoorthy
Tapas K Kundu
Anne-Laurence Boutillier
Laboratoire de Neurosciences Cognitives et Adaptatives · FRLaboratory of Molecular Genetics · PLJawaharlal Nehru Centre for Advanced Scientific Research · INLaboratoire de Neurosciences Cognitives · FRUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the brain functions of specific acetyltransferases such as the CREB-binding protein (CBP) and p300 have been well documented using mutant transgenic mice models, studies based on their direct pharmacological activation are still missing due to the lack of cell-permeable activators. Here we present a small-molecule (TTK21) activator of the histone acetyltransferases CBP/p300, which, when conjugated to glucose-based carbon nanosphere (CSP), passed the blood-brain barrier, induced no toxicity, and reached different parts of the brain. After intraperitoneal administration in mice, CSP-TTK21 significantly acetylated histones in the hippocampus and frontal cortex. Remarkably, CSP-TTK21 treatment promoted the formation of long and highly branched doublecortin-positive neurons in the subgranular zone of the dentate gyrus and reduced BrdU incorporation, suggesting that CBP/p300 activation favors maturation and differentiation of adult neuronal progenitors. In addition, mRNA levels of the neuroD1 differentiation marker and BDNF, a neurotrophin required for the terminal differentiation of newly generated neurons, were both increased in the hippocampus concomitantly with an enrichment of acetylated-histone on their proximal promoter. Finally, we found that CBP/p300 activation during a spatial training, while not improving retention of a recent memory, resulted in a significant extension of memory duration. This report is the first evidence for CBP/p300-mediated histone acetylation in the brain by an activator molecule, which has beneficial implications for the brain functions of adult neurogenesis and long-term memory. We propose that direct stimulation of acetyltransferase function could be useful in terms of therapeutic options for brain diseases.

Indexed as

AcetyltransferasesAnimalsBasic Helix-Loop-Helix ProteinsBrainBrain-Derived Neurotrophic FactorCell CountCell NucleusChromatin ImmunoprecipitationCREB-Binding ProteinDendritesEnzyme ActivatorsFluorescent Antibody TechniqueHippocampusHistone AcetyltransferasesHistonesImmunohistochemistryacetyl-CoA - lysine N6-acetyltransferaseAcetyltransferasesBasic Helix-Loop-Helix ProteinsBrain-Derived Neurotrophic FactorCREB-Binding ProteinEnzyme ActivatorsHistone AcetyltransferasesHistonesNeurod1 protein, mousep300-CBP Transcription Factors

Identifiers

PMID23804093
PMCPMC6618502
OpenAlexW2048364484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.